The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.

wikigene or wiki gene protein drug chemical gene disease author authorship tracking collaborative publishing evolutionary knowledge reputation system wiki2.0 global collaboration genes proteins drugs chemicals diseases compound

Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

[search][options]

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

Philip Kahl

Department of Pathology

University of Bonn Medical School

Sigmund Freud Street 25

53127 Bonn

Germany

[email]@ukb.uni-bonn.de

Name/email consistency: high

[Claim this account]

Affiliations

Department of Pathology, University of Bonn Medical School, Sigmund Freud Street 25, 53127 Bonn, Germany. 2007 - 2009
Institute of Pathology, University Hospital Bonn Medical School, Germany. 2006

References

Saturation biopsy improves preoperative Gleason scoring of prostate cancer. Kahl, P., Wolf, S., Adam, A., Heukamp, L.C., Ellinger, J., Vorreuther, R., Solleder, G., Buettner, R. Pathol. Res. Pract. (2009) [Pubmed]
Kaposi's sarcoma of the gastrointestinal tract: report of two cases and review of the literature. Kahl, P., Buettner, R., Friedrichs, N., Merkelbach-Bruse, S., Wenzel, J., Carl Heukamp, L. Pathol. Res. Pract. (2007) [Pubmed]
Orofaciodigital syndrome type IV (Mohr-Majewski syndrome): report of a family with two affected siblings. Kahl, P., Heukamp, L.C., Buettner, R., Friedrichs, N., Roesing, B., Knopfle, G. Pediatr. Dev. Pathol. (2007) [Pubmed]
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence. Kahl, P., Gullotti, L., Heukamp, L.C., Wolf, S., Friedrichs, N., Vorreuther, R., Solleder, G., Bastian, P.J., Ellinger, J., Metzger, E., Schüle, R., Buettner, R. Cancer Res. (2006) [Pubmed]